HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, ependymoma, epithelial neoplasm, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor	Active, not recruiting	Phase 1	2026-06-02		NCT04903080

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Baylor College of Medicine	267
Children's Oncology Group	79
National Cancer Institute (NCI)	3015
Texas Children's Cancer Center	2

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago	United States	144
Children's Healthcare of Atlanta	Atlanta	United States	38
Children's Hospital Colorado	Aurora	United States	312
Children's Hospital Los Angeles	Los Angeles	United States	4
Children's National Medical Center	Washington D.C.	United States	177
Cincinnati Children's Hospital Medical Center	Cincinnati	United States	405
Dana Farber Cancer Institute	Boston	United States	300
Memorial Sloan Kettering Cancer Center	New York	United States	1000
Nationwide Children's Hospital	Columbus	United States	309
Pittsburgh Children's Hospital of UPMC	Pittsburgh	United States	1
Texas Children's Cancer Center	Houston	United States	4
The Hospital for Sick Children	Toronto	Canada	17
University of Florida	Gainesville	United States	70